Clinical evaluation of a rapid antibody test kit “iFinDx COVID-19 IgM/IgG” for the diagnosis of SARS-CoV2 infection

---

Original Article

Author Details : Manjubhashini Prabhuram, Santhiya Sekar, Malini Manivannan, Soundravalli Varadan, Vidyapoornam Nagarajan*

Volume : 8, Issue : 2, Year : 2022

Article Page : 159-162

https://doi.org/10.18231/j.ijmmtd.2022.033

Suggest article by email

Get Permission

---

Abstract

The disease COVID-19 caused by SARS-CoV-2 that led to serious health problems since late 2019, and WHO announced as pandemic. The only diagnostic strategy available during pandemic was RT PCR used as the gold standard method, due to its high throughput procedure and high cost, the screening of patients would be difficult. Hence the antigen and antibody detecting rapid diagnostic kits were developed, that can be used as the point of care testing. The assessment of iFInDx COVID-19 IgM/IgG test kit was evaluated the sensitivity and specificity of the diagnostic kit with a total samples of 427 compared with ELISA and RT PCR method.
 

Keywords: COVID­19, RDT, Elisa, Ag­Ab interaction, RT­PCR

How to cite : Prabhuram M, Sekar S, Manivannan M, Varadan S, Nagarajan V, Clinical evaluation of a rapid antibody test kit “iFinDx COVID-19 IgM/IgG” for the diagnosis of SARS-CoV2 infection. IP Int J Med Microbiol Trop Dis 2022;8(2):159-162

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.